Nature, Vol.589, No.7842, 358-359, 2021
Psychedelics re-engineered for potential use in the clinic
An analogue of the psychedelic drug ibogaine has been developed. The analogue mirrors ibogaine's ability to treat addiction and depression in animal models, has fewer side effects and is much simpler to synthesize. A safer analogue of the psychedelic compound ibogaine.
Keywords:Drug discovery;Neuroscience